ifabotuzumab

ifab_thumb.png

Ifabotuzumab Phase 1 Results

vail_thumb.png

Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment

cancers_thumb.png

EphA3 Publication in 'Cancers'

plos_thumb.png

Hypoxia-Controlled EphA3 Marks a Human Endometrium-Derived Multipotent Mesenchymal Stromal Cell that Supports Vascular Growth